BR9406292A - Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso - Google Patents

Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso

Info

Publication number
BR9406292A
BR9406292A BR9406292A BR9406292A BR9406292A BR 9406292 A BR9406292 A BR 9406292A BR 9406292 A BR9406292 A BR 9406292A BR 9406292 A BR9406292 A BR 9406292A BR 9406292 A BR9406292 A BR 9406292A
Authority
BR
Brazil
Prior art keywords
taxotere
taxol
preparation
inclusion complex
cyclodextrins
Prior art date
Application number
BR9406292A
Other languages
English (en)
Inventor
Lajos Szente
Jozsef Szejili
Andrasne Vikmon
Original Assignee
Chinoin Gyagyszer S Vegyszeti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyagyszer S Vegyszeti filed Critical Chinoin Gyagyszer S Vegyszeti
Publication of BR9406292A publication Critical patent/BR9406292A/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR9406292A 1993-05-12 1994-05-09 Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso BR9406292A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9301373A HU213200B (en) 1993-05-12 1993-05-12 The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
PCT/HU1994/000012 WO1994026728A1 (en) 1993-05-12 1994-05-09 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use

Publications (1)

Publication Number Publication Date
BR9406292A true BR9406292A (pt) 1995-12-26

Family

ID=10983581

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406292A BR9406292A (pt) 1993-05-12 1994-05-09 Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso

Country Status (23)

Country Link
US (1) US6284746B1 (pt)
EP (1) EP0698018B1 (pt)
JP (1) JP3693341B2 (pt)
CN (1) CN1123030A (pt)
AT (1) ATE225340T1 (pt)
AU (1) AU693101B2 (pt)
BG (1) BG100207A (pt)
BR (1) BR9406292A (pt)
CA (1) CA2162716C (pt)
CZ (1) CZ291495A3 (pt)
DE (1) DE69431476T2 (pt)
DK (1) DK0698018T3 (pt)
ES (1) ES2184764T3 (pt)
FI (1) FI955424A (pt)
HU (1) HU213200B (pt)
IL (1) IL109613A (pt)
NO (1) NO954545D0 (pt)
OA (1) OA10323A (pt)
PL (1) PL311561A1 (pt)
PT (1) PT698018E (pt)
SK (1) SK140595A3 (pt)
WO (1) WO1994026728A1 (pt)
YU (1) YU26894A (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
ID26549A (id) * 1998-02-05 2001-01-18 Novartis Ag Komposisi-komposisi epotilon
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
TWI321054B (en) * 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
GB0127677D0 (en) * 2001-11-19 2002-01-09 Vianex S A Inclusion complex
US20040106199A1 (en) * 2002-12-02 2004-06-03 Eliseev Alexey V. Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media
CN100486645C (zh) * 2006-09-12 2009-05-13 南京师范大学 含有环糊精紫杉醇包合物的药物组合物及其制备方法
CN100411688C (zh) * 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
CN101278929B (zh) * 2007-04-02 2011-05-18 王效山 含有藤黄酸类化合物的药物及藤黄酸类化合物的包合物的制备方法
ES2310122B1 (es) * 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
ITMI20071321A1 (it) * 2007-07-04 2009-01-05 Sea Marconi Technologies Di Va Nanospugne a base di ciclodestrine come veicolo per farmaci antitumorali
CL2007003876A1 (es) * 2007-12-28 2008-03-07 Univ De Concepcion Y Lab Andro Complejo de inclusion que esta formado por disulfiram y ciclodextrina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de la dependencia de alcohol y cocaina.
US9492417B2 (en) 2008-08-21 2016-11-15 The Johns Hopkins University Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
WO2015108932A1 (en) * 2014-01-14 2015-07-23 The Johns Hopkins University Liposome compositions encapsulating modified cyclodextrin complexes and uses thereof
CN103920163B (zh) * 2014-03-14 2016-09-14 南京大学 一种紫杉醇复合物、制备方法及其应用
US10751306B2 (en) 2015-11-06 2020-08-25 The Johns Hopkins University Methods of treating liver fibrosis by administering 3-bromopyruvate
GB201715008D0 (en) * 2017-09-18 2017-11-01 Inst De Medicina Molecular Faculdade De Medicina Univ De Lisboa TRPV2 Antagonists
CN110755371B (zh) 2018-07-25 2021-08-31 比卡生物科技（广州）有限公司 一种注射用多西他赛组合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
JPS62120324A (ja) * 1985-11-20 1987-06-01 Nippon Junyaku Kk 有機物質の水溶化方法
JP2651567B2 (ja) * 1986-03-20 1997-09-10 花王株式会社 メチル化β−シクロデキストリン
IE62095B1 (en) * 1988-03-29 1994-12-14 Univ Florida Pharmaceutical formulations for parenteral use
JP2929108B2 (ja) * 1988-10-28 1999-08-03 株式会社資生堂 化粧料および粉末化粧料
IT1227626B (it) 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
JPH02200671A (ja) * 1989-01-30 1990-08-08 Agency Of Ind Science & Technol インドールを抽出分離する方法およびインドール包接分離用薬剤
JPH035438A (ja) * 1989-05-31 1991-01-11 Kaken Pharmaceut Co Ltd フルルビプロフェン包接化合物およびこの包接化合物を用いる消炎鎮痛剤
GB8920135D0 (en) * 1989-09-06 1989-10-18 Erba Carlo Spa Use of dehydrated cyclodextrins for improving drug dissolution
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
HU211648A9 (en) 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
EP0485614B1 (en) * 1990-05-21 1997-08-13 Toppan Printing Co., Ltd. Cyclodextrin derivative
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
JPH0753396A (ja) 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法および用途
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor

Also Published As

Publication number Publication date
HU213200B (en) 1997-03-28
ATE225340T1 (de) 2002-10-15
WO1994026728A1 (en) 1994-11-24
DE69431476D1 (de) 2002-11-07
FI955424A0 (fi) 1995-11-10
EP0698018B1 (en) 2002-10-02
EP0698018A1 (en) 1996-02-28
CA2162716C (en) 2005-03-08
AU7008194A (en) 1994-12-12
US6284746B1 (en) 2001-09-04
DK0698018T3 (da) 2003-02-10
DE69431476T2 (de) 2003-06-18
OA10323A (en) 1997-10-07
NO954545L (no) 1995-11-10
JP3693341B2 (ja) 2005-09-07
CA2162716A1 (en) 1994-11-24
BG100207A (bg) 1996-05-31
PL311561A1 (en) 1996-02-19
FI955424A (fi) 1995-11-10
JPH08510232A (ja) 1996-10-29
IL109613A (en) 1997-09-30
ES2184764T3 (es) 2003-04-16
PT698018E (pt) 2003-02-28
HU9301373D0 (en) 1993-09-28
IL109613A0 (en) 1994-08-26
NO954545D0 (no) 1995-11-10
SK140595A3 (en) 1996-10-02
CZ291495A3 (en) 1996-04-17
HUT68589A (en) 1995-06-28
AU693101B2 (en) 1998-06-25
CN1123030A (zh) 1996-05-22
YU26894A (sh) 1997-05-28

Similar Documents

Publication Publication Date Title
BR9406292A (pt) Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso
HUP9800688A2 (hu) Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények
MX9710479A (es) Extracto de iridaceas y composiciones que la contienen.
BR9307401A (pt) Composi-{es de extrato da casca de carvalho composi-{es sint-ticas relacionadas e m-todo de usar as mesmas
FR2718963B1 (fr) Nouvelle composition pharmaceutique à base de taxoïdes.
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
ATE219061T1 (de) Huperzin a analoge verbindungen
FR2708198B1 (fr) Composition cosmétique ou pharmaceutique, notamment dermatologique contenant un extrait de Tephrosia, en particulier Tephrosia purpurea.
ES2195040T3 (es) Conjugado que incluye un principio activo, un polipeptido y varios polieteres y su uso como medicamento.
FR2677248B1 (fr) Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de brunelle.
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
FI961938A (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
BR9611904A (pt) Dioxidos de ditiazol
AR003452A1 (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro [4.5]decano-2-propanamina y una composicion farmaceutica que lo comprende.
ATE136469T1 (de) Neue verwendung eines monoklonalen antikörpers
DE69012034T2 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
ATE105570T1 (de) Modifizierte menschliche anti-rh(d)-antikoerper.
UA27023C2 (uk) Спосіб профілактики та лікуваhhя серцево-судиhhих захворюваhь
IT8820226A0 (it) Fosfatidil n_acetil_l_serina, composizioni farmaceutiche che la contengono e processo per la sua preparazione.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal